Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Onsite with Mount Sinai's Newly Launched IBD Center
• 8 Recent Developments in IBS
• FDA Accepts New Drug Application for Oral Relistor Tablets for Opioid-induced Constipation
• FDA Approves Enteric Parasite Panel for Detecting Intestinal Parasites
• FDA Cites Safety Issues, Reclassifies C. difficile Toxin Gene Amplification Assays
• Intercept Begins Phase 3 Trial of Obeticholic Acid for NASH
• Manufacturer of Novel Short Bowel Syndrome Treatment Reports Positive FDA Meeting
• A Glimpse into Multidisciplinary IBD Practice
• HCV Council 2014 Recap Critical Appraisal of Data
• AGA Recommends Testing for Lynch Syndrome in All Patients With CRC
• Costs May Outweigh Benefits for Coverage of Anesthesia During Screening Colonoscopy
• Meta-analysis Supports Efficacy of Probiotic for Preventing Antibiotic-associated Diarrhea
• Molecular Testing Without Toxin Immunoassay May Overdiagnose C. difficile
• Newly Identified Gene Variants May Contribute to Development of Very Early Onset IBD
• Nutrigenetic Diet Does Not Increase Weight Loss Compared with Standard Balanced Diet
• Undiagnosed Nonceliac Gluten Sensitivity Symptomatic With Low Gluten
• ACG President Calls for Continued Improvement to ‘Maintenance of Competencies’
• Diabetes, Metabolic Syndrome Increase Risk for HCC
• Gastric Intestinal Metaplasia More Common in US Than Previously Thought
• HBV Common in Pregnant Haitians, Vaccination at Birth Suggested
• HepQuant-STAT Predicts HCV Patients’ Risk for Clinical Outcomes
• Video: Expert Discusses Diet as Emerging Cause, Management Strategy for GI Disease
• Expert Highlights Need to Prepare for ‘Exponential’ Rise in IBD
• New Formulation of IBgard Improves IBS Symptoms
• OCTAVE Trials: Xeljanz Induces Remission in Moderate-to-Severe UC